Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Drug Discovery Today" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Drug Discovery Today for you to read. Along with our medical data and news we also list Drug Discovery Today Clinical Trials, which are updated daily. BioPortfolio also has a large database of Drug Discovery Today Companies for you to search.
EU conference and two-day ‘hack the lab’ hackathon discusses how artificial intelligence (AI) and the Internet of Things (IoT) will impact life sciences
The topic of this month’s newsletter from Drug Discovery Today is “Peptides”
EU Manifesto on Influenza Vaccination launched detailing key strategies to improve influenza vaccination coverage rates in Europe
Findings published in Nature Communications identify stem cell survival pathway, which may serve as a potential target for new breast cancer therapies
The Phenomics Discovery Initiative (PDi) has expanded its assay portfolio to a total of 11 complex phenotypic assays that are relevant to human pathophysiology in areas of unmet clinical need including neuropsychiatric illnesses, dementia, cancer and respiratory infections.
Follicum AB have announced that the firstpatient has been treated in the Phase IIa clinical trial in Germany with its lead candidate FOL-005 on 60 patients with hair loss. The study is conducted at Clinical Research Center for Hair and Skin Science (“CRC”) in Berlin and bioskin, Hamburg, Germany. The global market for pharmaceutical hair lossproducts for both men and women is estimated to be ...
BC Platforms, a world leader in genomic data management and analytics, announces that it has been selected by Gene By Gene, the industry leader in offering integrated multi-disciplinary genetic testing services, to scale up its genomic data processing and storage capabilities.
Treatments targeted to enhance brain neurotrophic factor signalling could improve memory functions in Alzheimer’s disease even though they don’t alter brain amyloid burden, according to recent research from the University of Eastern Finland. The enhancement of brain derived neurotrophic factor (BDNF) signalling alleviated memory impairment in Alzheimer’s mouse models. In addition, the admini...
BC Platforms, a pioneer in genomic data management and analytics, today announces it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses the Microsoft Genomics service which runs on Microsoft Azure. GeneVision provides end-to-end Software-as-a-Service solution from raw genome data to patient reports, implemented using Azure services. GeneVision utilizes several o...
“It seems like every time you turn around, someone is talking about the importance of artificial intelligence and machine learning,” said Trey Ideker, PhD, University of California San Diego School of Medicine and Moores Cancer Center professor. “But all of these systems are so-called ‘black boxes.’ They can be very predictive, but we don’t actually know all that much about how they wo...
Memorandum of Understanding between CGT Catapult and JSRM further enhances the UK’s relationship with regenerative medicine centres in Japan and contributes to the advancement of cell and gene therapies worldwide
The topic of this month’s newsletter from Drug Discovery Today is “Regulatory aspects of Drug Discovery”.
Scottish Enterprise will contribute £2.7m via a ‘seek and solve’ grant to fund pre-clinical activities
The battle for supremacy between bacteria and antibiotics normally goes unseen, either behind closed doors in the laboratory or concealed deep within the human body. But now that complex contest is being translated into music thanks to a performance in which the worlds of art and science will combine to striking effect.
Start-ups working on a range of technologies and discoveries - from AI to immunotherapy - receive complimentary access to Elsevier's information solutions to accelerate innovation
The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, today announced that it is in the final stages of a BBSRC-funded collaboration project with the University of Edinburgh’s Roslin Institute, to transform the way in which valuable proteins are manufactured for research, veterinary and human health. The project, hosted at CPI’s state-of-...
The topic of this month’s newsletter from Drug Discovery Today is “Medicinal Chemistry””.
Trial protocols are needed for a proper assessment of the veracity of drug trial reports. The researchers, from the Nordic Cochrane Centre in Copenhagen, found widespread redactions in the protocols for commercially sponsored trials they received from research ethics committees in Denmark. The study is believed to be the first systematic assessment of which information in trial protocols pharmaceu...
‘Pipeline Progressing: the UK’s global bioscience cluster in 2017’ launched by the BioIndustry Association and Informa Pharma Intelligence
Bezlotoxumab is the first EC licensed non-antibiotic option indicated to prevent Clostridium difficile infection (CDI) recurrence in high-risk adults
94% expect an increase in use of Machine Learning within two years, but access to quality data and technical expertise is a barrier to adoption
Nintedanib has been designated a Promising Innovative Medicine for the treatment of malignant pleural mesothelioma (MPM) by the UK Medicine and Healthcare Products Regulatory Agency (MHRA). This is an early indication that the MHRA considers nintedanib a promising candidate for the Early Access to Medicines Scheme, which aims to give patients with life threatening or seriously debilitating conditi...
AstraZeneca and Imperial College London have announced a new research collaboration in respiratory disease which will see their scientists working side-by-side to investigate basic scientific mechanisms and underlying drivers of conditions such as asthma and chronic obstructive pulmonary disease (COPD).
The topic of this month’s newsletter from Drug Discovery Today is “the best of 2017””.
Two of the key organisations in the UK and Russia leading efforts to combat the global problem of antimicrobial resistance (AMR) have today announced a formal agreement to work together.